Antibiotics for pneumonia therapy

Medical Clinics of North America

Volumn 78, Issue 5, 1994, Pages 997-1014

  Mandell, L A ^a  

^a HENDERSON GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEM; CEFALOTIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOXACILLIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MACROLIDE; METRONIDAZOLE; MONOBACTAM DERIVATIVE; NAFCILLIN; NETILMICIN; OXACILLIN; PENICILLIN DERIVATIVE; PENICILLIN G; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; TICARCILLIN; TIMENTIN; UNINDEXED DRUG; VANCOMYCIN;

ACTIVE TRANSPORT; ANTIMICROBIAL THERAPY; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; HOSPITAL INFECTION; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PNEUMONIA; PRIORITY JOURNAL; PROTEIN BINDING; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 0028136999     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(16)30116-X     Document Type: Article

References (83)

1. D.R. Baldwin D. Honeybourne R. Wise Pulmonary disposition of antimicrobial agents: Methodological considerations Antimicrob Agents Chemother 36 1992 1171
2. J.G. Bartlett Anaerobic bacterial infections of the lung Chest 91 1987 901
3. M. Barza Pharmacokinetics of antibiotics L.D. Sabath Action of Antibiotics in Patients 1982 Hans Huber Bern 11
4. M. Barza G. Cuchural General principles of antibiotic tissue penetration J Antimicrob Chemother 15 suppl A 1985 59
5. C.R. Bodem L.M. Lampton D.P. Miller Endobronchial pH. Relevance to aminoglycoside activity in gram negative bacillary pneumonia Am Rev Respir Dis 127 1983 39
6. R.N. Brogden R.C. Heel T.M. Speight Metronidazole in anaerobic infections: A review of its activity, pharmacokinetics and therapeutic use Drugs 16 1978 387
7. A.G. Brown β-lactam nomenclature J Antimicrob Chemother 10 1982 365
8. R.B. Brown J.A. Kruse G.W. Counts Double-blind study of endotracheal tobramycin in the treatment of gram-negative bacterial pneumonia Antimicrob Agents Chemother 34 1990 269
9. R.W. Bundtzen A.U. Gerber D.L. Cohn Postantibiotic suppression of bacterial growth Rev Infect Dis 3 1981 28
10. J.J. Burchall G.H. Hitchings Inhibitor-binding analysis of dihydrofolate reductases from various species Molec Pharmacol 1 1965 126
11. S.R.M. Bushby Trimethoprim-sulfamethoxazole: In vitro microbiologic aspects J Infect Dis 128 suppl 1973 442
12. D.M. Campoli-Richards J.P. Monk A. Price Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use Drugs 35 1988 373
13. N-X Chin H.C. Neu Cefotaxime and desacetylcefotaxime: An example of advantageous antimicrobial metabolism Diagn Microbiol Infect Dis 2 1984 21S
14. A.W. Chow V. Patten L.B. Guze Susceptibility of anaerobic bacteria to metronidazole: Relative resistance of non-spore-forming gram-positive bacilli J Infect Dis 131 1975 182
15. R. Cleeland E. Squires Antimicrobial activity of ceftriaxone: A review Am J Med 77 1984 3
16. W.A. Craig Penicillins S.L. Gorbach J.G. Bartlett N.R. Blacklow Infectious Diseases 1992 WB Saunders Philadelphia 160
17. W.A. Craig Post-antibiotic effects in experimental infection models: Relationship to in- vitro phenomena and to treatment of infections in man J Antimicrob Chemother 31 suppl D 1993 149
18. B.A. Cunha Antibiotic pharmacokinetic considerations in pulmonary infections Semin Respir Infect 6 1991 168
19. B.D. Davis The lethal action of aminoglycosides J Antimicrob Chemother 22 1988 1
20. G.L. Drusano Role of pharmacokinetics in the outcome of infections Antimicrob Agents Chemother 32 1988 289
21. P.H. Edelstein Legionnaires' disease Clin Infect Dis 16 1993 741
22. P.H. Edelstein R.D. Meyer Legionella pneumonias J.E. Pennington Respiratory Infections: Diagnosis and Management 2 1988 Raven Press New York 381
23. R.M. Effros G.R. Mason K. Sietsema Pulmonary epithelial sieving of small solutes in rat lungs J Appl Physiol 65 1988 640
24. S.J. Eykyn The therapeutic use of metronidazole in anaerobic infection: Six years' experience in a London hospital Surgery 93 1983 209
25. J-Y Fagon J. Chastre Y. Domart Nosocomial pneumonia in patients receiving continuous mechanical ventilation Am Rev Respir Dis 139 1989 877
26. P.B. Fernandes N. Ramer R.A. Rode Bioassay for A-56268(TE-031) and identification of its major metabolite, 14-hydroxy-6-0 methylerythromycin Eur J Clin Microbiol Infect Dis 7 1988 73
27. D.W. Garrison R.M. DeHaan J.B. Lawson Comparison of in vitro antibacterial activities of 7-chloro-7-deoxylincomycin, lincomycin, and erythromycin Antimicrob Agents Chemother 1967 1968 397
28. D.N. Gerding L.L. Van Etta L.R. Peterson Role of serum protein binding and multiple antibiotic doses in the extra vascular distribution of ceftizoxime and cefotaxime Antimicrob Agents Chemother 22 1982 844
29. K.V. Gopalakrishna P.I. Lerner Tetracycline-resistant pneumococci: Increasing incidence and cross resistance to newer tetracyclines Am Rev Respir Dis 108 1973 1007
30. W.L. Hand N.L. King-Thompson Membrane transport of clindamycin in alveolar mac-rophages Antimicrob Agents Chemother 21 1982 241
31. D.J. Hardy D.M. Hensey J.M. Beyer Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides Antimicrob Agents Chemother 32 1988 1710
32. D.J. Hardy R.N. Swanson R.A. Rode Enhancement of the in vitro and in vivo activities of clarithromycin against Hemophilus influenzae by 14-hydroxy-clarithromy- cin, its major metabolite in humans Antimicrob Agents Chemother 34 1990 1407
33. D. Honeybourne D.R. Baldwin The site concentrations of antimicrobial agents in the lung J Antimicrob Chemother 30 1992 249
34. B.L. Johnston K. Forward T.J. Marrie Nosocomial pneumonia Chest Surg Clin North Am 1 1991 337
35. R.N. Jones Review of the in vitro spectrum and characteristics of cefmetazole (CS-1170) J Antimicrob Chemother 23 suppl D 1989 1
36. R.N. Jones Review of the in vitro spectrum of activity of imipenem Am J Med 78 suppl 6A 1985 22
37. M. Kaibara Y. Kikkawa Osmiophilia of the saturated phospholipid, dipalmitoyl lecithin, and its relationship to the alveolar lining layer of the mammalian lung Am J Anat 132 1971 61
38. J. Klastersky F. Carpentier-Meunier L. Kahan-Coppens Endotracheally administered antibiotics for gram-negative bronchopneumonia Chest 75 1979 586
39. R.C. Knight I.M. Skolimowski D.I. Edwards The interaction of reduced metronidazole with DNA Biochem Pharmacol 27 1978 2089
40. D.B. Louria L. Young J.K. Armstrong Smith Gentamicin in the treatment of pulmonary infections J Infect Dis 119 1969 483
41. B.J. Magerlein R.D. Birkenmeyer F. Kagan Clinical modification of lincomycin Antimicrob Agents Chemother 1966 1967 727
42. L.A. Mandell T.J. Marrie M.S. Niederman the Canadian Hospital Acquired Pneumonia Consensus Conference Group: Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report Can J Infect Dis 4 1993 317
43. L.A. Mandell M. Niederman the Canadian Community Acquired Pneumonia Consensus Conference Group: Antimicrobial treatment of community acquired pneumonia in adults: A conference report Can J Infect Dis 4 1993 25
44. R.C. Moellering Jr. In vitro antibacterial activity of the aminoglycoside antibiotics Rev Infect Dis 5 suppl 1983 S212
45. R.D. Moore C.R. Smith P.S. Lietman Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia Am J Med 77 1984 657
46. S. Morimoto Y. Takahashi Y. Watanabe Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-0-methy 1-erythromycin Am J Antibiot 37 1984 187
47. M.J. Mulligan C.G. Cobbs Bacteriostatic versus bactericidal activity Infect Dis Clin North Am 3 1989 389
48. H.C. Neu Penicillins G.L. Mandell R.G. Douglas Jr. J.E. Bennett Principles and Practice of Infectious Diseases 3 1990 Churchill Livingstone New York 230
49. M.S. Niederman J.B. Bass G.D. Campbell Guidelines for the initial empiric therapy of community acquired pneumonia: proceedings of an American Thoracic Society Consensus Conference Am Rev Respir Dis 148 1993 1418
50. J.P. O'Keefe K.A. Troc K.D. Thompson Activity of metronidazole and its hydroxy and acid metabolites against clinical isolates of anaerobic bacteria Antimicrob Agents Chemother 22 1982 426
51. R. Pallares F. Gudiol J. Linares Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci N Engl J Med 317 1987 18
52. A. Pascual I. Garcia E.J. Perea Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes Antimicrob Agents Chemother 33 1989 653
53. J.E. Pennington Penetration of antibiotics into respiratory secretions Rev Infect Dis 3 1981 67
54. J.E. Pennington J.B. Schiff C.B. Johnson Therapeutic lessons learned from pneumonia models H. Lode B. Kemmerich J. Klastersky Current Aspects of Bacterial and Non-Bacterial Pneumonias 1984 Georg Thieme Verlag Stuttgart, West Germany 61
55. S. Pestka Inhibitors of protein synthesis H. Weissbach S. Pestka Molecular Mechanisms of Protein Biosynthesis 1977 Academic Press New York 467
56. D.H. Peters H.A. Friedel D. McTavish Azithromycin. A review of its antimicrobial activity, pharmacokinetic properties and clinical efficacy Drugs 44 1992 750
57. R.R. Pfeiffer Structural features of vancomycin Rev Infect Dis 3 1981 S205
58. I. Phillips R. Fernandes C. Warren In vitro comparison of erythromycin, lincomycin and clindamycin BMJ 2 1970 89
59. R.C. Prokesch W.L. Hand Antibiotic entry into human polymorphonuclear leukocytes Antimicrob Agents Chemother 21 1982 373
60. V.J. Quagliarello W.J. Long W.M. Scheld Human interleukin-1 modulates blood-brain barrier injury in vivo 1987 Program and Abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy New York 204
61. V.J. Quagliarello W.J. Long W.M. Scheld Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat: Temporal sequence and role of encapsulation J Clin Invest 77 1986 1084
62. J. Rello V. Ausina J. Castella Nosocomial respiratory tract infections in multiple trauma patients Chest 102 1992 525
63. A.V. Reynolds J.M.T. Hamilton-Miller W. Brumfitt Diminished effect of gentamicin under anaerobic or hypercapnic conditions Lancet 1 1976 447
64. J.E. Rosenblatt R.S. Edson Metronidazole Mayo Clin Proc 62 1987 1013
65. J. Rubenis V.M. Kozik G.G. Jackson Laboratory studies on gentamicin Antimicrob Agents Chemother 1963 1964 153
66. C.C. Sanders W.E. Sanders R.V. Goering In vitro studies with SCH21420 and SCH22591: Activity in comparison with six other aminoglycosides and synergy with penicillin against enterococci Antimicrob Agents Chemother 14 1978 178
67. S. Schonwald M. Gunjaca L. Kolacny-Babic Comparison of azithromycin and erythromycin in the treatment of atypical pneumonias J Antimicrob Chemother 25 suppl A 1990 123
68. W.E. Siegenthaler A. Bonetti R. Luthy Aminoglycoside antibiotics in infectious diseases. An overview Am J Med 80 suppl 6B 1986 2
69. J.T. Smith C.S. Lewin Chemistry and mechanisms of action of the quinolone antibacteri- als V.T. Andriole The Quinolones 1988 Academic Press London 23
70. R.B. Sykes D.P. Bonner Discovery of and development of the monobactams Rev Infect Dis 7 suppl B 1985 579
71. R.B. Sykes D.P. Bonner Aztreonam: The first monobactam Am J Med 78 suppl 2A 1985 2
72. C. Thornsberry Review of in vitro activity of third-generation cephalosporins and other newer beta-lactam antibiotics against clinically important bacteria Am J Med 79 2A 1985 14
73. G.M. Trenholme P.P. McKellar N. Rivera Amikacin in the treatment of gram- negative pneumonia Am J Med 77 1984 657
74. Y. Valcke R. Pauwels M. Van Der Straeten Pharmacokinetics of antibiotics in the lungs Eur Respir J 3 1990 715
75. A. Ward D.M. Richards Cefotetan: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use Drugs 30 1985 382
76. C. Watanakunakorn Mode of action and in vitro activity of vancomycin J Antimicrob Chemother 14 suppl 1984 7
77. C. Watanakunakorn The antibacterial action of vancomycin Rev Infect Dis 3 1981 S210
78. R. Wise The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy Clin Pharmacokinet 11 1986 470
79. B. Wispelwey A.J. Lesse E.J. Hansen Haemophilus influenzae lipopolysaccharide- induced blood brain barrier permeability during experimental meningitis in the rat J Clin Invest 82 1988 1339
80. B. Wispelwey W.J. Long J.M. Castracane Cerebrospinal fluid interleukin-1 activity following intracistemal inoculation of Haemophilus influenzae lipopolysaccharide into rats 1988 Program and Abstracts of the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy Los Angeles 265
81. W.R. Wilson F.R. Cockerill III. Tetracyclines, chloramphenicol, erythromycin and clindamycin Mayo Clin Proc 62 1987 906
82. J.S. Wolfson D.C. Hooper Comparative pharmacokinetics of ofloxacin and ciprofloxacin Am J Med suppl 6C 1989 31S
83. J.S. Wolfson D.C. Hooper M.N. Swartz Mechanisms of action of and resistance to quinolone antimicrobial agents J.S. Wolfson D.C. Hooper Quinolone Antimicrobial Agents 1989 American Society for Microbiology Washington, DC 5